Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03035474 · ClinicalTrials.gov registry record · NA
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
A NA study of Heart Failure, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 5,749
- Enrollment target
- 20
- Study locations
NCT03035474: Completed NA study of Heart Failure, sponsored by Duke University.
NCT03035474 is a NA study of Heart Failure that has completed, run by Duke University. The registered enrollment target is 5,749 participants, above the 2,035-participant average among 397 other Heart Failure trials with a reported enrollment target (183% higher). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03035474, a NA study of Heart Failure, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,749 participants
- Enrollment target
- 20
- Study locations
Study Summary
CONNECT-HF is a large-scale, pragmatic, cluster-randomized clinical trial to evaluate the effect of a customized, multifaceted, health system-level quality-improvement (QI) program compared with usual care on heart failure (HF) outcomes and HF quality-of-care metrics.
Conditions Studied
Interventions
- OTHER Digital Engagement
- OTHER Direct Engagement
Study Locations (20)
California
- San Gorgonio Memorial Hospital - Banning
- Memorial Medical Center - Modesto
- Dignity Health Sequoia Hospital - Redwood City
- Riverside Community Hospital - Riverside
- Sutter Medical Center - Sacramento
- Stanford University - Stanford
- Torrance Memorial Medical Center - Torrance
Florida
- JFK Medical Center - Atlantis
- Manatee Memorial Hospital - Bradenton
- Blake Medical Center - Bradenton
- Broward Health Imperial Point - Fort Lauderdale
- Holy Cross Hospital - Fort Lauderdale
Colorado
- University of Colorado Hospital - Aurora
- UC Health Memorial - Colorado Springs
- Northern Colorado Medical Center - Greeley
Arkansas
- Sparks Regional Medical Center - Fort Smith
- Arkansas Heart Hospital and Clinics - Little Rock
Alabama
- University of Alabama Hospital - Birmingham
Alaska
- Providence Alaska Medical Center - Anchorage
Connecticut
- Stamford Hospital - Stamford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,749 participants |
| Start Date | 2017-04-21 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT03035474 record still lists
NCT03035474 is an interventional study that assigns participants to a tested intervention. Its 5,749 participants enrollment target places it among the larger protocols in the corpus, above the 2,035-participant average among 397 other Heart Failure trials with a reported enrollment target (183% higher).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Digital Engagement is the first listed.
NCT03035474 names 20 study sites across 7 states, led by California, Florida, Colorado.
Frequently Asked Questions
What is clinical trial NCT03035474 about?
NCT03035474 is a clinical study titled "Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure". CONNECT-HF is a large-scale, pragmatic, cluster-randomized clinical trial to evaluate the effect of a customized, multifaceted, health system-level quality-improvement (QI) program compared with usual care on heart failure (HF) outcomes and HF quality-of-care metrics.
What is the current status of trial NCT03035474?
This trial is currently completed. It is a NA study. The enrollment target is 5,749 participants. The study started on 2017-04-21. Estimated completion is 2020-12-31.
What conditions does trial NCT03035474 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT03035474?
The interventions under investigation include: Digital Engagement (OTHER), Direct Engagement (OTHER).
Who is sponsoring clinical trial NCT03035474?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03035474 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03035474's enrollment target sits among peer trials
5,749 14th of 397 higher than 384 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04983875 · 5,708 participants · NA
Mammography and Breast Arterial Calcification: An Information-Sharing Trial
- NCT06627335 · 5,621 participants
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
- NCT06981598 · 5,586 participants · NA
Prevention of Psychological Health Problems Via Integrated Operational Support
- NCT03959085 · 5,951 participants · Phase 3
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI